Literature DB >> 16648305

Leucine-rich repeat-containing G-protein-coupled receptor 8 in mature glomeruli of developing and adult rat kidney and inhibition by insulin-like peptide-3 of glomerular cell proliferation.

P Fu1, P-J Shen, C-X Zhao, D J Scott, C S Samuel, J D Wade, G W Tregear, R A D Bathgate, A L Gundlach.   

Abstract

Leucine-rich repeat-containing G-protein-coupled receptor 8 (LGR8, or RXFP2) is a member of the type C leucine-rich repeat-containing G protein-coupled receptor family, and its endogenous ligand is insulin-like peptide-3 (INSL3). Although LGR8 expression has been demonstrated in various human tissues, including testis, ovary, brain and kidney, the precise roles of this receptor in many of these tissues are unknown. In an effort to better understand INSL3-LGR8 systems in the rat, we cloned the full-length Lgr8 cDNA and investigated the presence and cellular localization of Lgr8 mRNA expression in adult and developing rat kidney. On the basis of these findings, we investigated the presence and distribution of renal 125I-labelled human INSL3-binding sites and the nature of INSL3-LGR8 signalling in cultured renal cells. Thus, using in situ hybridization histochemistry, cells expressing Lgr8 mRNA were observed in glomeruli of renal cortex from adult rats and were tentatively identified as mesangial cells. Quantitative, real-time PCR analysis of the developmental profile of Lgr8 mRNA expression in kidney revealed highest relative levels at late stage gestation (embryonic day 18), with a sharp decrease after birth and lowest levels in the adult. During development, silver grains associated with Lgr8 mRNA hybridization were observed overlying putative mesangial cells in mature glomeruli, with little or no signal associated with less-mature glomeruli. In adult and developing kidney, specific 125I-INSL3-binding sites were associated with glomeruli throughout the renal cortex. In primary cultures of glomerular cells, synthetic human INSL3 specifically and dose-dependently inhibited cell proliferation over a 48 h period, further suggesting the presence of functional LGR8 (receptors) on these cells (mesangial and others). These findings suggest INSL3-LGR8 signalling may be involved in the genesis and/or developmental maturation of renal glomeruli and possibly in regulating mesangial cell density in adult rat kidney.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648305     DOI: 10.1677/joe.1.06697

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  3 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

2.  Diverse functions of insulin-like 3 peptide.

Authors:  Maria Esteban-Lopez; Alexander I Agoulnik
Journal:  J Endocrinol       Date:  2020-10-01       Impact factor: 4.286

3.  Novel insights into the bovine polled phenotype and horn ontogenesis in Bovidae.

Authors:  Aurélie Allais-Bonnet; Cécile Grohs; Ivica Medugorac; Stefan Krebs; Anis Djari; Alexander Graf; Sébastien Fritz; Doris Seichter; Aurélia Baur; Ingolf Russ; Stéphan Bouet; Sophie Rothammer; Per Wahlberg; Diane Esquerré; Chris Hoze; Mekki Boussaha; Bernard Weiss; Dominique Thépot; Marie-Noëlle Fouilloux; Marie-Noëlle Rossignol; Este van Marle-Köster; Gunnfríður Elín Hreiðarsdóttir; Sarah Barbey; Dominique Dozias; Emilie Cobo; Patrick Reversé; Olivier Catros; Jean-Luc Marchand; Pascal Soulas; Pierre Roy; Brigitte Marquant-Leguienne; Daniel Le Bourhis; Laetitia Clément; Laura Salas-Cortes; Eric Venot; Maëlle Pannetier; Florence Phocas; Christophe Klopp; Dominique Rocha; Michel Fouchet; Laurent Journaux; Carine Bernard-Capel; Claire Ponsart; André Eggen; Helmut Blum; Yves Gallard; Didier Boichard; Eric Pailhoux; Aurélien Capitan
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.